Logo image of MRAM

EVERSPIN TECHNOLOGIES INC (MRAM) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:MRAM - US30041T1043 - Common Stock

9.38 USD
+0.08 (+0.86%)
Last: 12/26/2025, 8:03:50 PM
9.38 USD
0 (0%)
After Hours: 12/26/2025, 8:03:50 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to MRAM. MRAM was compared to 113 industry peers in the Semiconductors & Semiconductor Equipment industry. No worries on liquidiy or solvency for MRAM as it has an excellent financial health rating, but there are worries on the profitability. MRAM is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

MRAM had positive earnings in the past year.
In the past year MRAM had a positive cash flow from operations.
MRAM had positive earnings in 4 of the past 5 years.
Of the past 5 years MRAM 4 years had a positive operating cash flow.
MRAM Yearly Net Income VS EBIT VS OCF VS FCFMRAM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M -20M

1.2 Ratios

MRAM has a Return On Assets (-0.71%) which is comparable to the rest of the industry.
With a Return On Equity value of -0.86%, MRAM perfoms like the industry average, outperforming 43.36% of the companies in the same industry.
Industry RankSector Rank
ROA -0.71%
ROE -0.86%
ROIC N/A
ROA(3y)8.51%
ROA(5y)2.08%
ROE(3y)11.3%
ROE(5y)0.19%
ROIC(3y)N/A
ROIC(5y)N/A
MRAM Yearly ROA, ROE, ROICMRAM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 -400 -600 -800

1.3 Margins

MRAM's Profit Margin has declined in the last couple of years.
The Gross Margin of MRAM (51.31%) is better than 65.49% of its industry peers.
In the last couple of years the Gross Margin of MRAM has remained more or less at the same level.
MRAM does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 51.31%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-41.82%
PM growth 5YN/A
GM growth 3Y-4.74%
GM growth 5Y1.18%
MRAM Yearly Profit, Operating, Gross MarginsMRAM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

8

2. Health

2.1 Basic Checks

MRAM does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for MRAM has been increased compared to 1 year ago.
MRAM has more shares outstanding than it did 5 years ago.
There is no outstanding debt for MRAM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
MRAM Yearly Shares OutstandingMRAM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
MRAM Yearly Total Debt VS Total AssetsMRAM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

MRAM has an Altman-Z score of 7.62. This indicates that MRAM is financially healthy and has little risk of bankruptcy at the moment.
MRAM has a Altman-Z score of 7.62. This is in the better half of the industry: MRAM outperforms 66.37% of its industry peers.
MRAM has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 7.62
ROIC/WACCN/A
WACC10.69%
MRAM Yearly LT Debt VS Equity VS FCFMRAM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

2.3 Liquidity

MRAM has a Current Ratio of 5.84. This indicates that MRAM is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 5.84, MRAM belongs to the best of the industry, outperforming 81.42% of the companies in the same industry.
A Quick Ratio of 4.81 indicates that MRAM has no problem at all paying its short term obligations.
MRAM has a better Quick ratio (4.81) than 78.76% of its industry peers.
Industry RankSector Rank
Current Ratio 5.84
Quick Ratio 4.81
MRAM Yearly Current Assets VS Current LiabilitesMRAM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

3

3. Growth

3.1 Past

The earnings per share for MRAM have decreased strongly by -35.14% in the last year.
MRAM shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -4.88% yearly.
Looking at the last year, MRAM shows a decrease in Revenue. The Revenue has decreased by -0.41% in the last year.
The Revenue has been growing slightly by 6.09% on average over the past years.
EPS 1Y (TTM)-35.14%
EPS 3Y-4.88%
EPS 5YN/A
EPS Q2Q%-64.71%
Revenue 1Y (TTM)-0.41%
Revenue growth 3Y-2.96%
Revenue growth 5Y6.09%
Sales Q2Q%16.27%

3.2 Future

Based on estimates for the next years, MRAM will show a decrease in Earnings Per Share. The EPS will decrease by -9.20% on average per year.
The Revenue is expected to grow by 9.40% on average over the next years. This is quite good.
EPS Next Y-29.82%
EPS Next 2Y-3.26%
EPS Next 3Y-9.2%
EPS Next 5YN/A
Revenue Next Year10.47%
Revenue Next 2Y9.93%
Revenue Next 3Y9.4%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
MRAM Yearly Revenue VS EstimatesMRAM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M
MRAM Yearly EPS VS EstimatesMRAM Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -1 -2 -3 -4

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 40.78, which means the current valuation is very expensive for MRAM.
Based on the Price/Earnings ratio, MRAM is valued a bit cheaper than the industry average as 64.60% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 26.57, MRAM is valued quite expensively.
A Price/Forward Earnings ratio of 30.65 indicates a quite expensive valuation of MRAM.
Based on the Price/Forward Earnings ratio, MRAM is valued a bit cheaper than 61.06% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of MRAM to the average of the S&P500 Index (24.04), we can say MRAM is valued slightly more expensively.
Industry RankSector Rank
PE 40.78
Fwd PE 30.65
MRAM Price Earnings VS Forward Price EarningsMRAM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, MRAM is valued a bit cheaper than 69.91% of the companies in the same industry.
Industry RankSector Rank
P/FCF 45.84
EV/EBITDA N/A
MRAM Per share dataMRAM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

MRAM's earnings are expected to decrease with -9.20% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-3.26%
EPS Next 3Y-9.2%

0

5. Dividend

5.1 Amount

MRAM does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

EVERSPIN TECHNOLOGIES INC

NASDAQ:MRAM (12/26/2025, 8:03:50 PM)

After market: 9.38 0 (0%)

9.38

+0.08 (+0.86%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)11-05 2025-11-05/amc
Earnings (Next)02-24 2026-02-24/amc
Inst Owners59.75%
Inst Owner Change-3.64%
Ins Owners5.05%
Ins Owner Change1.08%
Market Cap214.43M
Revenue(TTM)53.64M
Net Income(TTM)-568.00K
Analysts82.5
Price Target10.71 (14.18%)
Short Float %1.74%
Short Ratio1.36
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)24.18%
Min EPS beat(2)17.65%
Max EPS beat(2)30.72%
EPS beat(4)4
Avg EPS beat(4)336.68%
Min EPS beat(4)17.65%
Max EPS beat(4)1207.19%
EPS beat(8)8
Avg EPS beat(8)401.03%
EPS beat(12)12
Avg EPS beat(12)293.44%
EPS beat(16)16
Avg EPS beat(16)625.95%
Revenue beat(2)0
Avg Revenue beat(2)-0.99%
Min Revenue beat(2)-1.54%
Max Revenue beat(2)-0.44%
Revenue beat(4)2
Avg Revenue beat(4)1.23%
Min Revenue beat(4)-1.54%
Max Revenue beat(4)3.87%
Revenue beat(8)4
Avg Revenue beat(8)0.67%
Revenue beat(12)8
Avg Revenue beat(12)1.3%
Revenue beat(16)12
Avg Revenue beat(16)1.75%
PT rev (1m)23.53%
PT rev (3m)23.53%
EPS NQ rev (1m)0%
EPS NQ rev (3m)4.55%
EPS NY rev (1m)7.14%
EPS NY rev (3m)28.57%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.35%
Revenue NY rev (1m)0.18%
Revenue NY rev (3m)0.18%
Valuation
Industry RankSector Rank
PE 40.78
Fwd PE 30.65
P/S 4
P/FCF 45.84
P/OCF 19.2
P/B 3.26
P/tB 3.37
EV/EBITDA N/A
EPS(TTM)0.23
EY2.45%
EPS(NY)0.31
Fwd EY3.26%
FCF(TTM)0.2
FCFY2.18%
OCF(TTM)0.49
OCFY5.21%
SpS2.35
BVpS2.88
TBVpS2.79
PEG (NY)N/A
PEG (5Y)N/A
Graham Number3.86
Profitability
Industry RankSector Rank
ROA -0.71%
ROE -0.86%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 51.31%
FCFM 8.72%
ROA(3y)8.51%
ROA(5y)2.08%
ROE(3y)11.3%
ROE(5y)0.19%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-41.82%
PM growth 5YN/A
GM growth 3Y-4.74%
GM growth 5Y1.18%
F-Score3
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 209.73%
Cap/Sales 12.1%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.84
Quick Ratio 4.81
Altman-Z 7.62
F-Score3
WACC10.69%
ROIC/WACCN/A
Cap/Depr(3y)192.66%
Cap/Depr(5y)132.94%
Cap/Sales(3y)4.31%
Cap/Sales(5y)3.11%
Profit Quality(3y)251.99%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-35.14%
EPS 3Y-4.88%
EPS 5YN/A
EPS Q2Q%-64.71%
EPS Next Y-29.82%
EPS Next 2Y-3.26%
EPS Next 3Y-9.2%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.41%
Revenue growth 3Y-2.96%
Revenue growth 5Y6.09%
Sales Q2Q%16.27%
Revenue Next Year10.47%
Revenue Next 2Y9.93%
Revenue Next 3Y9.4%
Revenue Next 5YN/A
EBIT growth 1Y-77.22%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1162.5%
EBIT Next 3Y181.26%
EBIT Next 5YN/A
FCF growth 1Y-66.03%
FCF growth 3Y-21.44%
FCF growth 5YN/A
OCF growth 1Y-31.56%
OCF growth 3Y-8.8%
OCF growth 5YN/A

EVERSPIN TECHNOLOGIES INC / MRAM FAQ

Can you provide the ChartMill fundamental rating for EVERSPIN TECHNOLOGIES INC?

ChartMill assigns a fundamental rating of 4 / 10 to MRAM.


Can you provide the valuation status for EVERSPIN TECHNOLOGIES INC?

ChartMill assigns a valuation rating of 2 / 10 to EVERSPIN TECHNOLOGIES INC (MRAM). This can be considered as Overvalued.


Can you provide the profitability details for EVERSPIN TECHNOLOGIES INC?

EVERSPIN TECHNOLOGIES INC (MRAM) has a profitability rating of 3 / 10.


What is the financial health of EVERSPIN TECHNOLOGIES INC (MRAM) stock?

The financial health rating of EVERSPIN TECHNOLOGIES INC (MRAM) is 8 / 10.